State-of-the-art technology combines single-cell capture with molecular indexing
NML at LGC once again one of four partners making their expertise available to successful applicants
The A4I programme provides companies with access to state-of-the-art measurement and analytical technologies
Addresses growing demand by labs
for a product to document Free Triiodothyronine linearity and calibration verification
Money will support the manufacture of future medicines through better measurement
Organic Analysis Team within NML working to investigate potential measurement improvements to support Newborn Blood Spot Screening programme
LGC operates out of 22 countries, with laboratories and centres across Europe and the US, as well as sites in Brazil, China and India.